Ueki H, Ogawa C, Goto H, Nishi M, et al. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia. Int J Hematol 2024 Jan 25. doi: 10.1007/s12185-024-03710.
PMID: 38267673